Stock Market News

1 month Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily

Bristol Myers Squibb stock rocketed Monday after AbbVie’s experimental schizophrenia treatment failed in a pair of midstage studies.
The post Bristol Rockets 11% As Investors Question AbbVie's $8.7 Billion 'Mistake' appeared first on Inv…

AbbVie (ABBV) · Bristol

9 hours AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks

16 hours BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer Zacks

5 days Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential – Bright 2026 Prospects Seeking Alpha

5 days Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued Seeking Alpha

5 days Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

5 days Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today Zacks

6 days Bristol Myers Squibb Stock Earns 83 RS Rating Investor's Business Daily

7 days Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know Zacks

7 days Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks

7 days Bristol-Myers: Still An Opportunity Yielding Over 4% Seeking Alpha

1 week AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

1 week AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors Zacks

1 week AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors Seeking Alpha

1 week Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy Investing.com

1 week BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

1 week ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

1 week ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

2 weeks Bristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should Know Zacks

2 weeks Betting Big On AbbVie: A Prescription For Growth And Dividends Seeking Alpha

2 weeks Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks

2 weeks Bristol Myers (BMY) Upgraded to Buy: Here’s Why Zacks

2 weeks AbbVie’s Recently Acquired Parkinson’s Drug Meets Third Study Goal Zacks

2 weeks Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now? Zacks

2 weeks The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

2 weeks Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

2 weeks AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025 MarketWatch

2 weeks AbbVie reports positive results in Parkinson’s trial Investing.com

3 weeks Calls of the Day: Toast, Abbvie, Berkshire Hathaway YouTube

3 weeks AbbVie Inc. (ABBV) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha

3 weeks Analyst Report: Bristol-Myers Squibb Co. Yahoo Finance

3 weeks Bristol-Myers Squibb Company (BMY) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha

3 weeks Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks

3 weeks Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks

3 weeks Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform Yahoo Finance

3 weeks Is Bristol-Myers Squibb Stock a Millionaire Maker? Yahoo Finance

4 weeks Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report? Zacks

4 weeks Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney YouTube

4 weeks Prime Medicine’s Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies Seeking Alpha

4 weeks Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead Seeking Alpha

4 weeks 5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade) Seeking Alpha

4 weeks AbbVie Stock Rises After Leerink Partners Upgrades Its Rating Zacks

1 month AbbVie: Upgrading To ‘Strong Buy’ After Pullback Seeking Alpha

1 month Trade Tracker: Jim Lebenthal buys more Abbvie YouTube

1 month AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily

1 month Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug Zacks

1 month AbbVie, Nvidia Lead Friday’s Market Cap Stock Movers Investing.com

1 month Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks

1 month Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks

1 month Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript) Seeking Alpha

1 month Where Will AbbVie Be in 5 Years? Yahoo Finance

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.